MARLEYPEN

This brand name is authorized in Nigeria.

Active ingredients

The drug MARLEYPEN contains one active pharmaceutical ingredient (API):

1	Benzylpenicillin UNII YS5LY7JF4N - PENICILLIN G SODIUM
	Benzylpenicillin is a beta-lactam antibiotic. It is bacteriocidal by inhibiting bacterial cell wall biosynthesis. Penicillin resistance can be mediated by alteration of penicillin binding proteins or development of beta-lactamases.
	Read more about Benzylpenicillin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2031	Injection	MARLEYPEN INJECTION INJ 600 mg 1X10VIALS	23 RNW-PP-122497 MARLEYPEN INJECTION BENZYLPENICILLIN SODIUM 1MEGA EACH VIAL CONTAINS BENZYLPENICILLIN SODIUM 1 MEGA EXCIPIENTS Sulfoxylate Disodium Edetate Povidone K30 Cetrimide B4-2031 Drugs Imported Products 1X10VIALS Prescription Only Medicine (POM) 1/22/2022 MARLEYSHREE PHARMACEUTICAL COMPANY NIGERIA LIMITED, , ZUNGERU ROAD, SABON GARI. KANO KANO 8063803298 marleyshreepharm2019@gmail.com CSPC ZHONGNUO PHARMACEUTICAL(SHIJIAZHUANG) CO. LTD., 88, YANGZI ROAD,HIGH INDUSTRY ZONE OF SHIJIAZHUANG, China	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CE01	Benzylpenicillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CE Beta-lactamase sensitive penicillins
Discover more medicines within J01CE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2031